Vancomycin iontophoresis of allograft bone

M C Edmondson1, R Day, D Wood

  • 1Royal Perth Hospital, PerthBone and Tissue Bank, Wellington Street, Perth, Australia.

Bone & Joint Research
|April 15, 2014
PubMed
Abstract

Insights

Iontophoresis effectively delivers vancomycin to allograft bone, despite initial concerns about the antibiotic

Area of Science:

  • Biomedical Engineering
  • Orthopedic Surgery
  • Infectious Disease

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant infection risk for allografts and surgical procedures.
  • Current iontophoresed antibiotics are ineffective against MRSA.
  • Vancomycin's large molecular size and lack of charge raised questions about its iontophoretic delivery through bone.

Purpose of the Study:

  • To determine the viability of iontophoresis for delivering vancomycin to bone allografts.
  • To optimize conditions for vancomycin iontophoresis in bone.

Main Methods:

  • An iontophoresis cell was used with sheep tibia sections.
  • Varying concentrations of vancomycin, times, and voltages were tested.
  • Vancomycin concentrations in bone were measured after serial washing.

Main Results:

  • Vancomycin was successfully delivered and impregnated into the bone allograft via iontophoresis.
  • Vancomycin concentration in the bone was significantly affected by solution concentration (p = 0.02774).
  • Delivery time showed a trend towards significance (p = 0.0597).

Conclusions:

  • Iontophoresis is a viable method for delivering vancomycin to allograft bone.
  • Vancomycin solution concentration influences bone concentration, but variability exists.
  • Further research is needed to explore iontophoresis for other antibiotics.

Related Concept Videos